EUVIMEDSkopri EUVIMED
Open access · CC BY-NC 4.0

Three-year post-recurrence survival outcome by leukopenia grade 2+ during systemic chemotherapy in recurrent cervical cancer

Pornpawee Wangsatidtongbai, Rakchai Buhachat, Ekasak Thiangphak

Obstetrics & Gynecology Science · 2026-05-15 · 69 (3) · 202-211

DOI: 10.5468/ogs.26032 ↗

At a glance

Journal article in Obstetrics & Gynecology Science, published on 2026-05-15. Written by Pornpawee Wangsatidtongbai and 2 co-authors. Institution: Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand. 25 references. The full text is freely available (open access, CC BY-NC 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

ObjectiveThis study aimed to evaluate the association between grade ≥2 chemotherapy-induced leukopenia (CIL) and 3-year post-recurrence survival (PRS) in patients with recurrent cervical cancer (CC) undergoing systemic chemotherapy.MethodsWe conducted a retrospective comparative cohort study of patients with recurrent CC who received ≥3 cycles of systemic chemotherapy at a tertiary referral center between January 2000 and June 2022. Complete serial blood counts were performed for each cycle. Patients were classified according to the development of grade ≥2 leukopenia (white blood cell count

Subjects

Author keywords

Antineoplastic combined chemotherapy protocolsLeukopeniaRecurrenceSurvival rateUterine cervical neoplasms

Authors and institutions

  • Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
  • Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand. brakchai@yahoo.com.

Cite

APA

Wangsatidtongbai, P., Buhachat, R., & Thiangphak, E. (2026). Three-year post-recurrence survival outcome by leukopenia grade 2+ during systemic chemotherapy in recurrent cervical cancer. Obstetrics & Gynecology Science, 69(3), 202-211. https://doi.org/10.5468/ogs.26032

Vancouver

Wangsatidtongbai P, Buhachat R, Thiangphak E. Three-year post-recurrence survival outcome by leukopenia grade 2+ during systemic chemotherapy in recurrent cervical cancer. Obstetrics & Gynecology Science. 2026;69(3):202-211. doi:10.5468/ogs.26032

BibTeX
@article{Wangsatidtongbai2026,
  author = {Wangsatidtongbai, Pornpawee and Buhachat, Rakchai and Thiangphak, Ekasak},
  title = {Three-year post-recurrence survival outcome by leukopenia grade 2+ during systemic chemotherapy in recurrent cervical cancer},
  journal = {Obstetrics & Gynecology Science},
  year = {2026},
  volume = {69},
  number = {3},
  pages = {202--211},
  doi = {10.5468/ogs.26032}
}
Start for free →